Generation bio cuts 40% of staff in blow for non-viral gene therapy sector
Pharmaceutical Technology
NOVEMBER 30, 2023
The move is a strategic response amid challenges faced by the non-viral gene therapy sector, with several startups closing this year.
Let's personalize your content